4.4 Article

Molecular signatures of Emery-Dreifuss muscular dystrophy

Journal

BIOCHEMICAL SOCIETY TRANSACTIONS
Volume 36, Issue -, Pages 1354-1358

Publisher

PORTLAND PRESS LTD
DOI: 10.1042/BST0361354

Keywords

beta-catenin; dilated cardiomyopathy; emerin; Emery-Dreifuss muscular dystrophy (EDMD); hypertrophy; lamin A/C

Funding

  1. BHF (British Heart Foundation) [PG/06/062/20926]

Ask authors/readers for more resources

Mutations in genes encoding the nuclear envelope proteins emerin and lamin A/C lead to a range of tissue-specific degenerative diseases. These include dilated cardiomyopathy, limb-girdle muscular dystrophy and X-linked and autosomal dominant EDMD (Emery-Dreifuss muscular dystrophy). The molecular mechanisms underlying these disorders are poorly understood; however, recent work using animal models has identified a number of signalling pathways that are altered in response to the deletion of either emerin or lamin A/C or expression of Lmna mutants found in patients with laminopathies. A distinguishing feature of patients with EDMD is the association of a dilated cardiomyopathy with conduction defects. in the present article, we describe several of the pathways altered in response to an EDMD phenotype, which are known to be key mediators of hypertrophic growth, and focus on a possible role of an emerin-beta-catenin interaction in the pathogenesis of this disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available